Nifty Pharma joins markets bull wagon; Alkem, Aurobindo led the pack

Amid mixed global signals, Nifty Pharma was trading green contributing to the gains of the benchmark Nifty 50 index. On Tuesday, Indian markets picked up momentum to trade higher and hit record highs as investors led buying sentiment in a longer term.

However, Nifty Pharma was limited due to selling pressure from heavyweights Torrent Pharma and Cipla. In contrast, Alkem, Divis Labs together with Aurobindo Pharma, Cadila led the sector earnings.

Around 11:15 a.m. M., Nifty Pharma has a yield of 14,555.50 points above 22.05 points or 0.15%. The index has touched an intraday high of 14,622.15 and an intraday low of 14,507.65 during the first trading session.

In the index, Alkem Laboratories acted as the top bull rising 1.52% to Rs3,568 per piece. The Company's independent net sales stood at Rs2,278.67cr, a year-on-year increase of 46.93%.

Aurobindo Pharma it was trading almost 1% higher at Rs 893.50 a piece.

Lupine Actions in focus as the major pharmaceutical company is set to announce its financial results today.

Cadila, Sun Pharma, Lupine were marginally higher to support the index while Dr. Reddys, Divis Lab and Biocon they traded on a flat note.

By contrast, heavyweights dragged the index down as equities witnessed a massive profit booking. Cipla lost 0.29% being the worst performer at Rs916 per piece, followed by Torrent Pharma down 0.08% to Rs3.071 per piece on the index.

Leave a Comment

Comments

No comments yet. Why donโ€™t you start the discussion?

Leave a Reply

Your email address will not be published. Required fields are marked *